Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Biolidics Ltd. ( (SG:8YY) ) has provided an update.
Embracing Future Holdings Limited has completed the allotment and issuance of new ordinary shares, increasing its total issued and paid-up share capital from 1,690,758,836 to 1,733,441,815 shares. This issuance, which includes various categories of shares such as Yuan Sign-On Shares and ECA Shares, is expected to be listed on the Catalist of the SGX-ST. The completion of this process marks a significant step in the company’s capital expansion strategy, potentially impacting its market positioning and offering new opportunities for stakeholders.
More about Biolidics Ltd.
Embracing Future Holdings Limited, formerly known as Biolidics Limited, is a company incorporated in Singapore. The company operates in the biotechnology sector, focusing on the development and commercialization of medical technology products. It is involved in the issuance of new ordinary shares to expand its share capital.
Average Trading Volume: 1,794,110
Technical Sentiment Signal: Hold
Current Market Cap: S$37.2M
For a thorough assessment of 8YY stock, go to TipRanks’ Stock Analysis page.